MTOR and neoplasm: Cells from tumor-like organoids remained heterozygous on days 135–160 of development and showed signs of mTOR activation at the same time, which suggests that a second hit at TSC1 or TSC2 is not required for tumor initiation, despite the appearance of a loss of heterozygosity during tumor progression.